CITIUS PHARMACEUTICALS INC's ticker is CTXR and the CUSIP is 17322U207. A total of 75 filers reported holding CITIUS PHARMACEUTICALS INC in Q4 2023. The put-call ratio across all filers is 0.04 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2024 | $3,000 | -90.0% | 3,036 | -92.3% | 0.00% | – |
Q4 2023 | $30,000 | +114.3% | 39,617 | +97.5% | 0.00% | – |
Q3 2023 | $14,000 | -6.7% | 20,061 | +60.8% | 0.00% | – |
Q2 2023 | $15,000 | – | 12,473 | +18242.6% | 0.00% | – |
Q3 2022 | $0 | -100.0% | 68 | -99.1% | 0.00% | – |
Q1 2022 | $14,000 | -61.1% | 7,612 | -67.3% | 0.00% | – |
Q4 2021 | $36,000 | +20.0% | 23,284 | +56.9% | 0.00% | – |
Q3 2021 | $30,000 | +11.1% | 14,842 | +90.5% | 0.00% | – |
Q2 2021 | $27,000 | – | 7,792 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GSA CAPITAL PARTNERS LLP | 498,783 | $394 | 0.05% |
Inspire Advisors, LLC | 195,946 | $154,797 | 0.04% |
Wealth Advisory Solutions, LLC | 155,850 | $123,122 | 0.03% |
Miller Investment Management, LP | 50,000 | $39,500 | 0.01% |
Virtu Financial LLC | 39,005 | $31 | 0.00% |
Pasadena Private Wealth, LLC | 10,965 | $8,662 | 0.00% |
Jump Financial, LLC | 49,251 | $38,908 | 0.00% |
Qube Research & Technologies Ltd | 120,580 | $95,258 | 0.00% |
TWO SIGMA SECURITIES, LLC | 61,613 | $48,674 | 0.00% |
Kestra Advisory Services, LLC | 93,717 | $74,036 | 0.00% |